DDIT3 and diffuse large B-cell lymphoma: National Comprehensive Cancer Network guidelines published in 2010 (ref. 33) recommended treating limited-stage DLBCL with either three cycles of R-CHOP and subsequent IFRT or six to eight cycles of R-CHOP (with or without subsequent IFRT).